Oncology Today with Dr Neil Love: Optimizing the Identification of HER2-Low Breast Cancer

Dr Kimberly H Allison from Stanford Cancer Institute in Stanford, California, discusses the optimal identification, pathologic reporting and treatment of HER2-low breast cancer.